Literature DB >> 17056261

Strategies for the management of bacterial brain abscess.

Cheng-Hsien Lu1, Wen-Neng Chang, Chen-Chung Lui.   

Abstract

We reviewed the medical and surgical management of brain abscess and compared the results of different methods of treatment. Treatment of brain abscess requires a combination of antimicrobial agents, surgical intervention, and eradication of the primary foci of infection. We believe that pathologic confirmation and/or microbiologic studies are needed to ensure proper management, with the selection of antibiotics based on the available culture and susceptibility results. A 6- to 8-week course of parenteral antibiotics, plus regular follow-up computed tomography scans for at least 3 months to evaluate the therapeutic response is also recommended. The method of surgical treatment is of lesser importance than adherence to the basic principles of abscess management, and which surgical treatment is chosen depends on the patient's clinical status, the neuroradiographic characteristics of the abscess, and the experience of the surgeons who will be carrying out the procedure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056261     DOI: 10.1016/j.jocn.2006.01.048

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  32 in total

Review 1.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Clinical features and outcome analysis of 90 cases with brain abscess in central China.

Authors:  Laijun Song; Fuyou Guo; Wei Zhang; Hongwei Sun; Jiang Long; Shukai Wang; Jianji Bao
Journal:  Neurol Sci       Date:  2008-11-11       Impact factor: 3.307

3.  Management of otogenic brain abscess using the transmastoid approach.

Authors:  June Choi; Jong Il Choi; Sang-Dae Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-03-31

4.  Utilization of multidisciplinary surgical techniques to successfully manage 20 brain abscesses in a child.

Authors:  Mohammed M Al Barbarawi; Wail A Hayajneh; Mohammad Y Hiasat; Mohammed Z Allouh
Journal:  Childs Nerv Syst       Date:  2014-03-07       Impact factor: 1.475

5.  MRI detection of bacterial brain abscesses and monitoring of antibiotic treatment using bacCEST.

Authors:  Jing Liu; Renyuan Bai; Yuguo Li; Verena Staedtke; Shuixing Zhang; Peter C M van Zijl; Guanshu Liu
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

6.  Roles of Toll-like receptor 2 (TLR2) and superantigens on adaptive immune responses during CNS staphylococcal infection.

Authors:  Debbie Vidlak; Monica M Mariani; Amy Aldrich; Shuliang Liu; Tammy Kielian
Journal:  Brain Behav Immun       Date:  2010-09-22       Impact factor: 7.217

7.  Diagnostic and management of pediatric brain stem abscess, a case-based update.

Authors:  Houssine Ghannane; Mehdi Laghmari; Khalid Aniba; Mohammed Lmejjati; Saïd Ait Benali
Journal:  Childs Nerv Syst       Date:  2011-04-06       Impact factor: 1.475

8.  The role of f-fluorodeoxyglucose positron emission tomography in the treatment of brain abscess.

Authors:  Seong-Hyun Park; Sang-Woo Lee; Dong-Hun Kang; Jeong-Hyun Hwang; Joo-Kyung Sung; Sung-Kyoo Hwang
Journal:  J Korean Neurosurg Soc       Date:  2011-05-31

9.  Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess.

Authors:  Tammy Kielian; Nilufer Esen; Shuliang Liu; Nirmal K Phulwani; Mohsin M Syed; Napoleon Phillips; Koren Nishina; Ambrose L Cheung; Joseph D Schwartzman; Jorg J Ruhe
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

10.  The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.

Authors:  Tammy Kielian; Mohsin Md Syed; Shuliang Liu; Nirmal K Phulwani; Napoleon Phillips; Gail Wagoner; Paul D Drew; Nilufer Esen
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.